Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Dec;48(12):1751-1759.
doi: 10.1007/s00134-022-06919-3. Epub 2022 Nov 18.

Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial

Affiliations
Randomized Controlled Trial

Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial

Gonzalo Hernández et al. Intensive Care Med. 2022 Dec.

Erratum in

Abstract

Purpose: High-flow nasal cannula (HFNC) oxygen therapy was noninferior to noninvasive ventilation (NIV) for preventing reintubation in a heterogeneous population at high-risk for extubation failure. However, outcomes might differ in certain subgroups of patients. Thus, we aimed to determine whether NIV with active humidification is superior to HFNC in preventing reintubation in patients with ≥ 4 risk factors (very high risk for extubation failure).

Methods: Randomized controlled trial in two intensive care units in Spain (June 2020‒June 2021). Patients ready for planned extubation with ≥ 4 of the following risk factors for reintubation were included: age > 65 years, Acute Physiology and Chronic Health Evaluation II score > 12 on extubation day, body mass index > 30, inadequate secretions management, difficult or prolonged weaning, ≥ 2 comorbidities, acute heart failure indicating mechanical ventilation, moderate-to-severe chronic obstructive pulmonary disease, airway patency problems, prolonged mechanical ventilation, or hypercapnia on finishing the spontaneous breathing trial. Patients were randomized to undergo NIV with active humidification or HFNC for 48 h after extubation. The primary outcome was reintubation rate within 7 days after extubation. Secondary outcomes included postextubation respiratory failure, respiratory infection, sepsis, multiorgan failure, length of stay, mortality, adverse events, and time to reintubation.

Results: Of 182 patients (mean age, 60 [standard deviation (SD), 15] years; 117 [64%] men), 92 received NIV and 90 HFNC. Reintubation was required in 21 (23.3%) patients receiving NIV vs 35 (38.8%) of those receiving HFNC (difference -15.5%; 95% confidence interval (CI) -28.3 to -1%). Hospital length of stay was lower in those patients treated with NIV (20 [12‒36.7] days vs 26.5 [15‒45] days, difference 6.5 [95%CI 0.5-21.1]). No additional differences in the other secondary outcomes were observed.

Conclusions: Among adult critically ill patients at very high-risk for extubation failure, NIV with active humidification was superior to HFNC for preventing reintubation.

Trial registration: ClinicalTrials.gov NCT04125342.

Keywords: Active humidification; High-flow nasal cannula; Noninvasive ventilation; Outcome; Reintubation; Weaning.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the ICMJE Form for disclosure of potential conflicts of interest. GH reported travel expenses and personal fees from Fisher & Paykel Healthcare Ltd. OR reported a research grant from Hamilton Medical AG, speaker fees from Hamilton Medical AG, Fisher&Paykel Healthcare Ltd, Aerogen Ltd and Ambu, and non-financial research support from Timpel; all outside the submitted work.

Figures

Fig. 1
Fig. 1
Flowchart of participants in a study comparing postextubation noninvasive ventilation with active humidification vs high-flow oxygen therapy for preventing reintubation in very high-risk patients. MV mechanical ventilation; SBT spontaneous breathing trial; NIV noninvasive ventilation with active humidification; HFNC high-flow nasal cannula
Fig. 2
Fig. 2
Kaplan–Meier analysis of time from extubation to reintubation

Comment in

References

    1. Ouellette DR, Patel S, Girard TD, et al. Liberation from mechanical ventilation in critically ill adults: an official American College of Chest Physicians/American Thoracic Society clinical practice guideline. Chest. 2017;151(1):166–180. doi: 10.1016/j.chest.2016.10.036. - DOI - PubMed
    1. Rochberg B, Brochard L, Elliott MW, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J. 2017;50(2):1602426. doi: 10.1183/13993003.02426-2016. - DOI - PubMed
    1. Rochwerg B, Einav S, Chaudhuri D, et al. The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020;46(12):2226–2237. doi: 10.1007/s00134-020-06312-y. - DOI - PMC - PubMed
    1. Thille AW, Muller G, Gacouin A, et al. Effect of postextubation high-flow nasal oxygen with noninvasive ventilation vs high-flow nasal oxygen alone on reintubation among patients at high risk of extubation failure: a randomized clinical trial. JAMA. 2019;322(15):1465–1475. doi: 10.1001/jama.2019.14901. - DOI - PMC - PubMed
    1. Nava S, Gregoretti C, Fanfulla F, et al. Noninvasive ventilation to prevent respiratory failure after extubation in high-risk patients. Crit Care Med. 2005;33:2465–2470. doi: 10.1097/01.CCM.0000186416.44752.72. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources